Track upcoming PDUFA dates, clinical trial readouts, and FDA advisory committees across 362+ biotech catalysts. Click any catalyst to view full details, dilution risk, and related signals.
FDA catalysts are regulatory events that can significantly impact biotech stock prices. The most important catalyst types include PDUFA dates (Prescription Drug User Fee Act deadlines), AdCom meetings (FDA Advisory Committee meetings), and clinical trial readouts (Phase 1, 2, and 3 data releases).
BiotechSigns tracks all upcoming catalysts across 800+ biotech and pharmaceutical companies, providing real-time monitoring of FDA decisions, insider trading activity, dilution risk, and more. Use this page to identify upcoming catalysts and click through to individual pages for detailed analysis.